CD8A and acute myeloid leukemia: An interesting aspect in the treatment of AML is the prospect of combining HMA with peptide vaccinations, as it has been shown that HMA enhances the expression of TAA, most notably NY-ESO as well as increases the amount of cancer germline antigen (CGA)-specific CD8+ T cells [18].